article Open AccessTop 1% cited
The A4 Study: Stopping AD Before Symptoms Begin?
Science Translational Medicine · 2014 · Vol. 6(228) · pp. 228fs13–228fs13
Reisa A. Sperling✉(Harvard University)Dorene M. Rentz(Harvard University)Keith A. Johnson(Harvard University)Jason Karlawish(University of Pennsylvania)Michael DonohueDavid P. SalmonPaul Aisen
Abstract
A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer's disease dementia should provide insights into whether anti-amyloid therapy can delay cognitive decline.
Health Systems, Economic Evaluations, Quality of LifeDementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and TreatmentsMedicineIntensive care medicine
MeSH terms
Alzheimer DiseaseAmyloidHumans
Citations
761
FWCI
252.90
field-weighted impact
References
11
Percentile
100%
vs. same field & year
Citations per year
Cited by
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Brain · 2018 · 1,774 citations
References
Statins for the primary prevention of cardiovascular disease
Cochrane Database of Systematic Reviews · 2013 · 1,829 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.